There are now over 56 specialized and professional researchers in our research and development team. We value every outstanding personnel and devote to give more opportunities for passing down a high-grade legacy in the field of pharmaceutical industry. Over 198 drug products approved by Food and Drug Administration have met the BA/BE (Bioavailability/Bioequivalence) and clinical trial criteria. Six extended-release products and two orally disintegrating products have won gold, silver and bronze medals for of the Manufacturing Technology of Drug Research and Development Science and Technology Award from the FDA. Our application of Solid Dispersion Technology has been recognized with Taipei Biotech Awards (Merit Award). Based on our unique and leading technology, we have established many distinctive dosage models and controlled-release drug manufacturing platforms that have brought us many pharmaceutical technology research and development awards.
2021 Taipei Biotech Awards (Application of Solid Dispersion Technology) –Merit Award
2013 Zotan Orally Disintegrating Tablets 0.2 mg – Bronze medal
2012 Olan Orally Disintegrating Tablets 5 mg –Bronze medal
2011 Glibudon XR Tablets 750 mg – Sliver medal
2010 Xadosin S.R.F.C. Tablets 4 mg –Gold medal
2009 Setizin-CP S.R.F.C. Tablets – Sliver medal
2008 Finska-LP 24 Hour S.R.F.C. Tablets – Sliver medal
2006 Finska-LP S.R.F.C. Tablets – Sliver medal
2005 Nifecardia S.R.F.C. Tablets 30 mg – Sliver medal
|